The global Biopsy Devices Market, valued at US$6.86 billion in 2023, is forecasted to grow at a robust CAGR of 7.2%, reaching US$7.27 billion in 2024 and an impressive US$11.01 billion by 2030. The ...

The global Biopsy Devices Market, valued at US$6.86 billion in 2023, is forecasted to grow at a robust CAGR of 7.2%, reaching US$7.27 billion ...

The latest research report published by Vantage Market Research, titled "An Increase in Demand and Opportunities for the ...

DELRAY BEACH, Fla., Feb. 25, 2025 /PRNewswire/ -- The global endoscopic ultrasonography market, valued at US$1.28 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, reaching US$1.37 ...

Based on product, the endoscopic ultrasonography market is divided into endoscopes, ultrasound processors, ultrasound probes, ...

The global biosurgery market is projected to grow at a CAGR of 5% from 2025 to 2030. This growth is driven by the increasing ...

Medtronic has a twelve month low of $75.96 and a twelve month high of $93.08. The company has a market cap of $119.28 billion, a price-to-earnings ratio of 28.45, a PEG ratio of 2.57 and a beta of ...

Shares of NYSE MDT opened at $93.02 on Wednesday. The stock’s 50-day simple moving average is $85.33 and its 200-day simple moving average is $86.72. The company has a debt-to-equity ratio of 0. ...